Hashtag
The Times

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
  • Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory follicular lymphoma (R/R FL) (Grade 1-3a).1,2
  • Despite the availability of existing treatments, R/R FL...

Read more: MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

Health & Wellness

Looking After a Hearing Aid: The Small Daily Habits That Matter

Hashtag.net.au - avatar Hashtag.net.au

A hearing aid is a small electronic device worn close to skin, sweat and earwax, and it needs regular care to keep working as it should. Most of that care is simple and takes only a minute or two, b...

What to Look for When Choosing a Dental Clinic Melbourne Patients Can Rely On

Hashtag.net.au - avatar Hashtag.net.au

Look at the Range of Dental Care Available Choosing a dental practice is easier when patients can access different types of care in one place. A dental clinic Melbourne patients visit may provide gen...

What Do Clinical Teams Need from Their Surgical Supply Partners?

Hashtag.net.au - avatar Hashtag.net.au

In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...

hacklink esim usazlibraryzlibraryz-libraryFanatikbetjojobetjustintvJojobet Girişcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevanttaraftariumjojobethacklink panelmarsbahisJojobet Girişnot on gamestopuk casinos not on gamstopyasal bahis siteleri